ALR Technologies SG Pte. Ltd (“ALRT”) and Diabetes Singapore Execute a Memorandum of Understanding to Form a Collaboration
The program will expand the availability of the ALRT Diabetes Solution to Singapore Residents
SINGAPORE, Aug. 31, 2020 (GLOBE NEWSWIRE) -- ALR Technologies Inc. (“ALRT”) (OTCQB: ALRT), is pleased to announce that its wholly owned subsidiary ALR Technologies SG Pte. Ltd has executed a
Memorandum of Understanding (MOU) with Diabetes Singapore, a full member in the International Diabetes Federation (IDF). The MOU outlines a collaboration between the two parties to raise the diabetes
management standard in Singapore.
The collaboration intends to develop a diabetes management program for the current and prospective members of Diabetes Singapore. The ALRT Diabetes Solution (the “Solution”) will be the bedrock of this program. The Solution is a unique diabetes management platform that leverages blood glucose testing data to give healthcare providers a window into their patients’ level of control between clinic visits. The Solution also provides suggestions for therapy advancement that are derived from evidence-based clinical guidelines. All the requisite hardware (glucose meter, test strips, lancets, and lancing device) is provided at no additional cost. ALRT will donate part of the proceeds to Diabetes Singapore.
Benefits of the ALRT Diabetes Solution for Diabetes Singapore:
- Members of Diabetes Singapore will enjoy a special price for the ALRT Diabetes Solution.
- The Solution will process and analyze blood glucose data to assist Diabetes Singapore nurse educators in their coordination of care for members.
- Diabetes Singapore will receive matching funds for donations from this collaboration to enhance coordination of care and counselling for their members.
- Diabetes Singapore also will use donated and matching funds to give subsidies to patients who require financial assistance.
“We are thrilled to work with Diabetes Singapore to contain the rampant diabetes onslaught with next-generation technology to flatten the curve,” commented Sidney Chan, Chief Executive Officer of ALRT. “Singapore’s position as a center of influence in the massive Western Pacific markets will showcase the impact that the Solution will have in improving patients’ outcomes and lifestyles while containing overall healthcare costs for other organizations and governments in the region.”